FDA launches "new use initiative".
D000970:Antineoplastic Agents / Q000592:standards / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000592:standards / Q000627:therapeutic use; D001688:Biological Products / Q000592:standards / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000592:standards; D006801:Humans; D015337:Multicenter Studies as Topic / Q000592:standards; D009369:Neoplasms / Q000628:therapy*; D011785:Quality Assurance, Health Care; D014481:United States; D014486:United States Food and Drug Administration; D015215:Zidovudine / Q000592:standards / Q000627:therapeutic use
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D001688:Biological Products; D015215:Zidovudine